Figure 8. Evaluation of overlapping DEGs in active SLE patients
with decreased Srsf1 levels.
A. RNA-sequencing data from one dataset (Kyogoku et. al.,
GSE51997) (Kyogoku et al., 2013) of active SLE patients versus healthy
controls was analyzed using NCBI GEO2R for Srsf1 mRNA expression.B . Graph shows significant decrease of Srsf1 expression
levels in CD4+ T cells in SLE patients (n=6) versus healthy controls
(n=4) (p=0.004). C. Venn diagram shows numbers of overlapping
genes.
Table 1. Table shows the sources of SLE datasets curated from
NCBI GEO2R and literature searches.
Table 2. Table shows top five pathways represented by the
overlapping DEGs between SLE patients and Srsf1-ko mice.
Table 3. Table shows 11 genes from one dataset (Kyogoku et al.,
2013) and associated biological processes and protein function of each
gene.
Supplementary Table 1. List of human homologues of DEGs
identified in Srsf1-KO mice
Supplementary Table 2. List of excluded mouse specific DEGs
(not found in humans equivalent data)
Supplementary table 3 . Overlapping mouse and human DEGs
Supplementary Table 4. Selection and analysis of cellular
pathways of the genes involved in the top 3 significant modules using
MCODE
Supplementary Table 5. List of predicted targets regulated by
RNA-binding of SRSF1 protein
Supplementary Table 6. List of predicted targets regulated by
RNA-binding of SRSF1 protein.
Supplementary Table 7. List of the overlapping DEGs between
Srsf1-KO mice and cohort of SLE patients with low SRSF1.